Home
About
FAQ
History (23)
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging.
Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients.
Skeletal-Related Events After Surgery With or Without Radiotherapy for Bone Metastases to Weight-Bearing Bones.
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.
Ranganathan A, Powell BL. Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia. Clin Lymphoma Myeloma Leuk. 2010 Oct; 10 Suppl 3:S135-8.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Humans
Leukemia, Promyelocytic, Acute
Recurrence
Risk Factors
Survival Analysis
Time Factors
Treatment Outcome
authors with profiles
Bayard L. Powell MD